-
公开(公告)号:US20240026432A1
公开(公告)日:2024-01-25
申请号:US18029995
申请日:2021-10-15
Applicant: AMGEN INC.
Inventor: Neil Soice , Scott Kuhns , Andrew Csordas
IPC: C12Q1/6848 , C12Q1/6806
CPC classification number: C12Q1/6848 , C12Q1/6806
Abstract: The disclosure provides materials and methods for assessing the presence and level of polyanionic compounds in a sample that inhibit PCR reactions, including assays for the presence, and optionally the amount, of polyvinyl sulfonate, as well as materials and methods for the reduction or removal of such compounds from buffer solutions and from protein solutions using a variety of approaches, including titration-based techniques.
-
公开(公告)号:US20240051990A1
公开(公告)日:2024-02-15
申请号:US18268772
申请日:2022-03-10
Applicant: AMGEN INC.
Inventor: Neil Soice , Jeremy S. Conner , Glenn M. Hunter , Kenneth Shoemaker , Bret Wylie , John B. Flynn , Nakorn Kaeonil , Thuy N. Nguyen , Siddharth Singh
IPC: C07K1/36
CPC classification number: C07K1/36
Abstract: Parallel chromatography systems and continuous manufacturing methods are described herein that utilize two or more chromatography column skids having columns operating in parallel with automation controls governing which column to load at a given time.
-
公开(公告)号:US20240075406A1
公开(公告)日:2024-03-07
申请号:US18268683
申请日:2022-02-17
Applicant: AMGEN INC.
Inventor: Jeremy S. Conner , Glenn M. Hunter , Kenneth Shoemaker , Neil Soice , Bret Wylie , John B. Flynn , Nakorn Kaeonil , Thuy N. Nguyen , Siddharth Sigh
CPC classification number: B01D15/1885 , C07K1/16
Abstract: Parallel chromatography systems and continuous manufacturing methods are described herein that utilize two or more chromatography column skids having columns operating in parallel with automation controls governing which column to load at a given time.
-
公开(公告)号:US20210395298A1
公开(公告)日:2021-12-23
申请号:US17283135
申请日:2019-10-11
Applicant: AMGEN INC.
Inventor: Pavel Bondarenko , Pik Chan , Neil Soice
Abstract: The present invention provides an improved manufacturing method for the production of bispecific antibody products, which comprise at least two binding domains. The process comprises at least the method comprising a step of refolding the construct, wherein one or more of the domains comprise a disulfide bond, and wherein the construct is contacted with a refolding buffer to refold the construct to its native form, the buffer comprising (i) a redox and/or oxidizing agent having a concentration of at least 0.1 mM and (ii) a chaotropic agent having a concentration >1 M, and wherein the pH of the refolding buffer corresponds to +/−4.5 of the pI value of the first domain or +/−4.0 of the pI value of the entire construct.
-
-
-